USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
U.S. Hepatitis C Market
U.S. Hepatitis C Market
RELEASE DATE
11-Oct-2011
11-Oct-2011
REGION
North America
North America
Research Code: NA1C-01-00-00-00
SKU: MX00109-NA-MR_17848
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
MX00109-NA-MR_17848
Description
This research service covers the U.S. hepatitis C (HCV) market from 2008 to 2016, with 2010 as the base year. Included are products on the market, products in development, and patient and revenue forecasts. Market challenges, drivers, and restraints are identified and assessed.
The market is segmented by classes of drug: interferons, protease inhibitors, nucleotide polymerase inhibitors, non-nucleotide polymerase inhibitors, NS5a's, and other classes. Included are examinations of therapeutic candidates on the market and in the HCV late-stage pipeline.
Table of Contents
Analysis of the U.S. Hepatitis C Market
- Research Service
This research service covers the U.S. hepatitis C (HCV) market from 2008 to 2016, with 2010 as the base year. Included are products on the market, products in development, and patient and revenue forecasts. Market challenges, drivers, and restraints are identified and assessed.
The market is segmented by classes of drug: interferons, protease inhibitors, nucleotide polymerase inhibitors, non-nucleotide polymerase inhibitors, NS5a's, and other classes. Included are examinations of therapeutic candidates on the market and in the HCV late-stage pipeline.
| No Index | Yes |
|---|---|
| Podcast | No |
| Author | Jennifer Lazar |
| Industries | Healthcare |
| WIP Number | NA1C-01-00-00-00 |
| Is Prebook | No |